Exact Mass: 756.1093642

Exact Mass Matches: 756.1093642

Found 37 metabolites which its exact mass value is equals to given mass value 756.1093642, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

P1,P2-Bis(5-adenosyl) triphosphate

P(1),P(2)-bis(5-adenosyl) triphosphate

C20H27N10O16P3 (756.0819332)


   

Diadenosine triphosphate

{[(2S,3R,4S,5S)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphinic acid

C20H27N10O16P3 (756.0819332)


Diadenosine triphosphate (AP3A) is a diadenosine polyphosphate. Diadenosine polyphosphates (APnAs, n = 3-6) are a family of endogenous vasoactive purine dinucleotides which have been isolated from thrombocytes. APnAs have been demonstrated to be involved in the control of vascular tone as well as the growth of vascular smooth muscle cells and hence, possibly, in atherogenesis. APnAs isolated substances are Ap3A, Ap4A, Ap5A, and Ap6A. APnAs are naturally occurring substances that facilitate tear secretion; they are released from the corneal epithelium, they stimulate tear production and therefore they may be considered as physiological modulators of tear secretion. The APnAs were discovered in the mid-sixties in the course of studies on aminoacyl-tRNA synthetases (aaRS). APnAs have emerged as intracellular and extracellular signalling molecules implicated in the maintenance and regulation of vital cellular functions and become considered as second messengers. Great variety of physiological and pathological effects in mammalian cells was found to be associated with alterations of APnAs. APnAs are polyphosphated nucleotidic substances which are found in the CNS and are known to be released in a calcium-dependent manner from storage vesicles in brain synaptosomes. AP3A is a primer for oligoadenylate synthesis catalyzed by interferon-inducible 2-5A synthetase. AP3A is synthesized in cells by tryptophanyl-tRNA synthetase (WRS); cellular level of AP3A significantly increases after interferon treatment. AP3A is an avid inhibitor of eosinophil-derived neurotoxin (EDN). EDN is a catalytically proficient member of the pancreatic ribonuclease superfamily secreted along with other eosinophil granule proteins during innate host defense responses and various eosinophil-related inflammatory and allergic diseases. The ribonucleolytic activity of EDN is central to its antiviral and neurotoxic activities and possibly to other facets of its biological activity. AP3A accumulates in cells in response to various physiological factors. AP3A FHIT (Fragile histidine Triad) is a human tumor suppressor gene. The Fhit protein is believed to inhibit tumor growth by inducing apoptosis through interaction with AP3A. (PMID: 11212966, 12738682, 11810214, 9607303, 8922753, 9187362, 16401072, 12833632, 11896678). Diadenosine triphosphate (AP3A) is a diadenosine polyphosphate. Diadenosine polyphosphates (APnAs, n = 3-6) are a family of endogenous vasoactive purine dinucleotides which have been isolated from thrombocytes. APnAs have been demonstrated to be involved in the control of vascular tone as well as the growth of vascular smooth muscle cells and hence, possibly, in atherogenesis. APnAs isolated substances are Ap3A, Ap4A, Ap5A, and Ap6A. APnAs are naturally occurring substances that facilitate tear secretion; they are released from the corneal epithelium, they stimulate tear production and therefore they may be considered as physiological modulators of tear secretion. The APnAs were discovered in the mid-sixties in the course of studies on aminoacyl-tRNA synthetases (aaRS). APnAs have emerged as intracellular and extracellular signalling molecules implicated in the maintenance and regulation of vital cellular functions and become considered as second messengers. Great variety of physiological and pathological effects in mammalian cells was found to be associated with alterations of APnAs. APnAs are polyphosphated nucleotidic substances which are found in the CNS and are known to be released in a calcium-dependent manner from storage vesicles in brain synaptosomes. AP3A is a primer for oligoadenylate synthesis catalyzed by interferon-inducible 2-5A synthetase. AP3A is synthesized in cells by tryptophanyl-tRNA synthetase (WRS); cellular level of AP3A significantly increases after interferon treatment. AP3A is an avid inhibitor of eosinophil-derived neurotoxin (EDN). EDN is a catalytically proficient member of the pancreatic ribonuclease superfamily secreted along with other eosinophil granule proteins during innate host defense responses and various eosinophil-related inflammatory and allergic diseases. The ribonucleolytic activity of EDN is central to its antiviral and neurotoxic activities and possibly to other facets of its biological activity. AP3A accumulates in cells in response to various physiological factors.

   

Syzyginin B

3,4,5,12,13,21,25,26,27-nonahydroxy-8,18-dioxo-9,14,17,23,30-pentaoxahexacyclo[17.12.0.0²,⁷.0¹⁰,¹⁵.0²²,³¹.0²⁴,²⁹]hentriaconta-1(19),2,4,6,20,22(31),24(29),25,27-nonaen-11-yl 3,4,5-trihydroxybenzoate

C33H24O21 (756.0810054)


Ellagitannin isolated from Syzygium aromaticum (clove). Syzyginin B is found in herbs and spices and cloves. Syzyginin B is found in cloves. Ellagitannin isolated from Syzygium aromaticum (clove

   

AP3A-lyophilized

bis[({[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphinic acid

C20H27N10O16P3 (756.0819332)


   

Ppapa

({[({1,2-bis[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]ethoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid

C20H27N10O16P3 (756.0819332)


   
   

3-hydroxyphloretin 4-O-(3,4-di-O-galloyl-beta-D-glucopyranoside)

3-hydroxyphloretin 4-O-(3,4-di-O-galloyl-beta-D-glucopyranoside)

C35H32O19 (756.1537722)


   

1-O-(4-hydroxybenzoyl)-2,3,5-tri-O-galloyl-alpha/beta-D-hamamelofuranose

1-O-(4-hydroxybenzoyl)-2,3,5-tri-O-galloyl-alpha/beta-D-hamamelofuranose

C34H28O20 (756.1173888000001)


   

3,4,6-Tri-O-galloylsalidroside

3,4,6-Tri-O-galloylsalidroside

C35H32O19 (756.1537722)


   
   

Syzyginin B

3,4,5,12,13,21,25,26,27-nonahydroxy-8,18-dioxo-9,14,17,23,30-pentaoxahexacyclo[17.12.0.0^{2,7}.0^{10,15}.0^{22,31}.0^{24,29}]hentriaconta-1(19),2,4,6,20,22(31),24(29),25,27-nonaen-11-yl 3,4,5-trihydroxybenzoate

C33H24O21 (756.0810054)


   

(s,s)-1,2-ethanediyl-bis-[(2-methoxyphenyl)-phenylphosphine]]-(1,5-cyclooctadiene)-rhodium(i)]-tetrafluoroborate

(s,s)-1,2-ethanediyl-bis-[(2-methoxyphenyl)-phenylphosphine]]-(1,5-cyclooctadiene)-rhodium(i)]-tetrafluoroborate

C36H40BF4O2P2Rh (756.1587608)


   

(r,r)-(-)-1,2-bis[(o-methoxyphenyl)(phenyl)phosphino]ethane(1,5-cyclooctadiene)rhodium (i) tetrafluoroborate

(r,r)-(-)-1,2-bis[(o-methoxyphenyl)(phenyl)phosphino]ethane(1,5-cyclooctadiene)rhodium (i) tetrafluoroborate

C36H40BF4O2P2Rh (756.1587608)


   

benzylbis(triphenylphosphine)palladium(ii) chloride

benzylbis(triphenylphosphine)palladium(ii) chloride

C43H37ClP2Pd (756.1093642)


   

Bis[di-(tert-butyl)(4-trifluoromethylphenyl)phosphine]palladium(II) chloride

Bis[di-(tert-butyl)(4-trifluoromethylphenyl)phosphine]palladium(II) chloride

C30H44Cl2F6P2Pd (756.1234086)


   

[1,2-Bis[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]ethoxy-hydroxyphosphoryl] phosphono hydrogen phosphate

[1,2-Bis[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]ethoxy-hydroxyphosphoryl] phosphono hydrogen phosphate

C20H27N10O16P3 (756.0819332)


   
   
   

P(1),P(2)-bis(5-adenosyl) triphosphate

P(1),P(2)-bis(5-adenosyl) triphosphate

C20H27N10O16P3 (756.0819332)


   

p(1),p(3)-Bis(5-adenosyl) triphosphate

p(1),p(3)-Bis(5-adenosyl) triphosphate

C20H27N10O16P3 (756.0819332)


A diadenosyl triphosphate having the two 5-adenosyl residues attached at the P(1)- and P(3)-positions.

   

3-hydroxy-2-[2-(4-hydroxyphenyl)ethoxy]-5-(3,4,5-trihydroxybenzoyloxy)-6-[(3,4,5-trihydroxybenzoyloxy)methyl]oxan-4-yl 3,4,5-trihydroxybenzoate

3-hydroxy-2-[2-(4-hydroxyphenyl)ethoxy]-5-(3,4,5-trihydroxybenzoyloxy)-6-[(3,4,5-trihydroxybenzoyloxy)methyl]oxan-4-yl 3,4,5-trihydroxybenzoate

C35H32O19 (756.1537722)


   

(2r,3r,4r,5r,6r)-3-hydroxy-2-[2-(4-hydroxyphenyl)ethoxy]-5-(3,4,5-trihydroxybenzoyloxy)-6-[(3,4,5-trihydroxybenzoyloxy)methyl]oxan-4-yl 3,4,5-trihydroxybenzoate

(2r,3r,4r,5r,6r)-3-hydroxy-2-[2-(4-hydroxyphenyl)ethoxy]-5-(3,4,5-trihydroxybenzoyloxy)-6-[(3,4,5-trihydroxybenzoyloxy)methyl]oxan-4-yl 3,4,5-trihydroxybenzoate

C35H32O19 (756.1537722)


   

(1s,2s,3s,11r,14s)-2-hydroxy-3-[(1s,2s,3r,11r,14s)-2-hydroxy-14-[(1s)-1-hydroxyethyl]-18-methyl-13,17-dioxo-15,16-dithia-10,12,18-triazapentacyclo[12.2.2.0¹,¹².0³,¹¹.0⁴,⁹]octadeca-4,6,8-trien-3-yl]-14-[(1s)-1-hydroxyethyl]-18-methyl-15,16-dithia-10,12,18-triazapentacyclo[12.2.2.0¹,¹².0³,¹¹.0⁴,⁹]octadeca-4,6,8-triene-13,17-dione

(1s,2s,3s,11r,14s)-2-hydroxy-3-[(1s,2s,3r,11r,14s)-2-hydroxy-14-[(1s)-1-hydroxyethyl]-18-methyl-13,17-dioxo-15,16-dithia-10,12,18-triazapentacyclo[12.2.2.0¹,¹².0³,¹¹.0⁴,⁹]octadeca-4,6,8-trien-3-yl]-14-[(1s)-1-hydroxyethyl]-18-methyl-15,16-dithia-10,12,18-triazapentacyclo[12.2.2.0¹,¹².0³,¹¹.0⁴,⁹]octadeca-4,6,8-triene-13,17-dione

C32H32N6O8S4 (756.1164392)


   

3,4,5,12,13,21,25,26,27-nonahydroxy-8,18-dioxo-9,14,17,23,30-pentaoxahexacyclo[17.12.0.0²,⁷.0¹⁰,¹⁵.0²²,³¹.0²⁴,²⁹]hentriaconta-1(31),2(7),3,5,19,21,24,26,28-nonaen-11-yl 3,4,5-trihydroxybenzoate

3,4,5,12,13,21,25,26,27-nonahydroxy-8,18-dioxo-9,14,17,23,30-pentaoxahexacyclo[17.12.0.0²,⁷.0¹⁰,¹⁵.0²²,³¹.0²⁴,²⁹]hentriaconta-1(31),2(7),3,5,19,21,24,26,28-nonaen-11-yl 3,4,5-trihydroxybenzoate

C33H24O21 (756.0810054)


   

(1s,2s,3s,11r,14s)-2-hydroxy-3-[(1s,2s,3s,11r,14s)-2-hydroxy-14-[(1s)-1-hydroxyethyl]-18-methyl-13,17-dioxo-15,16-dithia-10,12,18-triazapentacyclo[12.2.2.0¹,¹².0³,¹¹.0⁴,⁹]octadeca-4,6,8-trien-3-yl]-14-[(1s)-1-hydroxyethyl]-18-methyl-15,16-dithia-10,12,18-triazapentacyclo[12.2.2.0¹,¹².0³,¹¹.0⁴,⁹]octadeca-4,6,8-triene-13,17-dione

(1s,2s,3s,11r,14s)-2-hydroxy-3-[(1s,2s,3s,11r,14s)-2-hydroxy-14-[(1s)-1-hydroxyethyl]-18-methyl-13,17-dioxo-15,16-dithia-10,12,18-triazapentacyclo[12.2.2.0¹,¹².0³,¹¹.0⁴,⁹]octadeca-4,6,8-trien-3-yl]-14-[(1s)-1-hydroxyethyl]-18-methyl-15,16-dithia-10,12,18-triazapentacyclo[12.2.2.0¹,¹².0³,¹¹.0⁴,⁹]octadeca-4,6,8-triene-13,17-dione

C32H32N6O8S4 (756.1164392)


   

6-{4-[3-(3,4-dihydroxyphenyl)propanoyl]-3,5-dihydroxyphenoxy}-4,5-dihydroxy-2-[(3,4,5-trihydroxybenzoyloxy)methyl]oxan-3-yl 3,4,5-trihydroxybenzoate

6-{4-[3-(3,4-dihydroxyphenyl)propanoyl]-3,5-dihydroxyphenoxy}-4,5-dihydroxy-2-[(3,4,5-trihydroxybenzoyloxy)methyl]oxan-3-yl 3,4,5-trihydroxybenzoate

C35H32O19 (756.1537722)


   

(2s,3r,4r,5r,6r)-2-{4-[3-(3,4-dihydroxyphenyl)propanoyl]-3,5-dihydroxyphenoxy}-3-hydroxy-6-(hydroxymethyl)-5-(3,4,5-trihydroxybenzoyloxy)oxan-4-yl 3,4,5-trihydroxybenzoate

(2s,3r,4r,5r,6r)-2-{4-[3-(3,4-dihydroxyphenyl)propanoyl]-3,5-dihydroxyphenoxy}-3-hydroxy-6-(hydroxymethyl)-5-(3,4,5-trihydroxybenzoyloxy)oxan-4-yl 3,4,5-trihydroxybenzoate

C35H32O19 (756.1537722)


   

2-{4-[3-(3,4-dihydroxyphenyl)propanoyl]-3,5-dihydroxyphenoxy}-3-hydroxy-6-(hydroxymethyl)-5-(3,4,5-trihydroxybenzoyloxy)oxan-4-yl 3,4,5-trihydroxybenzoate

2-{4-[3-(3,4-dihydroxyphenyl)propanoyl]-3,5-dihydroxyphenoxy}-3-hydroxy-6-(hydroxymethyl)-5-(3,4,5-trihydroxybenzoyloxy)oxan-4-yl 3,4,5-trihydroxybenzoate

C35H32O19 (756.1537722)


   

(10r,11r,12r,13r,15r)-3,4,5,12,13,21,25,26,27-nonahydroxy-8,18-dioxo-9,14,17,23,30-pentaoxahexacyclo[17.12.0.0²,⁷.0¹⁰,¹⁵.0²²,³¹.0²⁴,²⁹]hentriaconta-1(31),2(7),3,5,19,21,24,26,28-nonaen-11-yl 3,4,5-trihydroxybenzoate

(10r,11r,12r,13r,15r)-3,4,5,12,13,21,25,26,27-nonahydroxy-8,18-dioxo-9,14,17,23,30-pentaoxahexacyclo[17.12.0.0²,⁷.0¹⁰,¹⁵.0²²,³¹.0²⁴,²⁹]hentriaconta-1(31),2(7),3,5,19,21,24,26,28-nonaen-11-yl 3,4,5-trihydroxybenzoate

C33H24O21 (756.0810054)


   

2-hydroxy-3-[2-hydroxy-14-(1-hydroxyethyl)-18-methyl-13,17-dioxo-15,16-dithia-10,12,18-triazapentacyclo[12.2.2.0¹,¹².0³,¹¹.0⁴,⁹]octadeca-4,6,8-trien-3-yl]-14-(1-hydroxyethyl)-18-methyl-15,16-dithia-10,12,18-triazapentacyclo[12.2.2.0¹,¹².0³,¹¹.0⁴,⁹]octadeca-4,6,8-triene-13,17-dione

2-hydroxy-3-[2-hydroxy-14-(1-hydroxyethyl)-18-methyl-13,17-dioxo-15,16-dithia-10,12,18-triazapentacyclo[12.2.2.0¹,¹².0³,¹¹.0⁴,⁹]octadeca-4,6,8-trien-3-yl]-14-(1-hydroxyethyl)-18-methyl-15,16-dithia-10,12,18-triazapentacyclo[12.2.2.0¹,¹².0³,¹¹.0⁴,⁹]octadeca-4,6,8-triene-13,17-dione

C32H32N6O8S4 (756.1164392)


   

(2r,3s,4r,5r,6s)-6-{4-[3-(3,4-dihydroxyphenyl)propanoyl]-3,5-dihydroxyphenoxy}-4,5-dihydroxy-2-[(3,4,5-trihydroxybenzoyloxy)methyl]oxan-3-yl 3,4,5-trihydroxybenzoate

(2r,3s,4r,5r,6s)-6-{4-[3-(3,4-dihydroxyphenyl)propanoyl]-3,5-dihydroxyphenoxy}-4,5-dihydroxy-2-[(3,4,5-trihydroxybenzoyloxy)methyl]oxan-3-yl 3,4,5-trihydroxybenzoate

C35H32O19 (756.1537722)


   

[3-hydroxy-2-(4-hydroxybenzoyloxy)-4-(3,4,5-trihydroxybenzoyloxy)-5-[(3,4,5-trihydroxybenzoyloxy)methyl]oxolan-3-yl]methyl 3,4,5-trihydroxybenzoate

[3-hydroxy-2-(4-hydroxybenzoyloxy)-4-(3,4,5-trihydroxybenzoyloxy)-5-[(3,4,5-trihydroxybenzoyloxy)methyl]oxolan-3-yl]methyl 3,4,5-trihydroxybenzoate

C34H28O20 (756.1173888000001)


   

[(2s,3r,4r,5r)-3-hydroxy-2-(4-hydroxybenzoyloxy)-4-(3,4,5-trihydroxybenzoyloxy)-5-[(3,4,5-trihydroxybenzoyloxy)methyl]oxolan-3-yl]methyl 3,4,5-trihydroxybenzoate

[(2s,3r,4r,5r)-3-hydroxy-2-(4-hydroxybenzoyloxy)-4-(3,4,5-trihydroxybenzoyloxy)-5-[(3,4,5-trihydroxybenzoyloxy)methyl]oxolan-3-yl]methyl 3,4,5-trihydroxybenzoate

C34H28O20 (756.1173888000001)


   

(1s,2s,3s,11r,14s)-2-hydroxy-3-[(1s,2s,3s,11r,14s)-2-hydroxy-14-(1-hydroxyethyl)-18-methyl-13,17-dioxo-15,16-dithia-10,12,18-triazapentacyclo[12.2.2.0¹,¹².0³,¹¹.0⁴,⁹]octadeca-4,6,8-trien-3-yl]-14-(1-hydroxyethyl)-18-methyl-15,16-dithia-10,12,18-triazapentacyclo[12.2.2.0¹,¹².0³,¹¹.0⁴,⁹]octadeca-4,6,8-triene-13,17-dione

(1s,2s,3s,11r,14s)-2-hydroxy-3-[(1s,2s,3s,11r,14s)-2-hydroxy-14-(1-hydroxyethyl)-18-methyl-13,17-dioxo-15,16-dithia-10,12,18-triazapentacyclo[12.2.2.0¹,¹².0³,¹¹.0⁴,⁹]octadeca-4,6,8-trien-3-yl]-14-(1-hydroxyethyl)-18-methyl-15,16-dithia-10,12,18-triazapentacyclo[12.2.2.0¹,¹².0³,¹¹.0⁴,⁹]octadeca-4,6,8-triene-13,17-dione

C32H32N6O8S4 (756.1164392)